• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Shimon Slavin, Arnon Nagler, +12 authors Reuven Or
  • Medicine
  • Blood
  • 1998 (First Publication: 1 February 1998)
  • Myeloablative conditioning associated with hazardous immediate and late complications is considered as a mandatory first step in preparation for allogeneic blood or marrow transplantation (allogeneicContinue Reading
  • Anna Sureda, Stephen D Robinson, +11 authors Norbert Schmitz
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2008 (First Publication: 20 January 2008)
  • PURPOSE To compare the clinical outcome in terms of nonrelapse mortality (NRM), relapse rate (RR), overall survival (OS), and progression-free survival (PFS) in patients with relapsed Hodgkin'sContinue Reading
  • Alessandro Aiuti, Barbara Cassani, +15 authors Claudio Bordignon
  • Medicine, Biology
  • The Journal of clinical investigation
  • 2007 (First Publication: 1 August 2007)
  • Gene transfer into HSCs is an effective treatment for SCID, although potentially limited by the risk of insertional mutagenesis. We performed a genome-wide analysis of retroviral vector integrationsContinue Reading
  • Hae Kyung Lee, Susan Finniss, +9 authors Chaya Brodie
  • Medicine, Biology
  • Oncotarget
  • 2013 (First Publication: 1 February 2013)
  • MicroRNAs (miRNAs) have emerged as potential cancer therapeutics; however, their clinical use is hindered by lack of effective delivery mechanisms to tumor sites. Mesenchymal stem cells (MSCs) haveContinue Reading
  • Malek Aoudjhane, Myriam Labopin, +17 authors Vanderson Rocha
  • Medicine
  • Leukemia
  • 2005 (First Publication: 1 December 2005)
  • Results of reduced intensity conditioning regimen (RIC) in the HLA identical haematopoietic stem cell transplantation (HSCT) setting have not been compared to those after myeloablative (MA) regimenContinue Reading
  • Parameswaran Hari, Jeanette Carreras, +17 authors Koen M van Besien
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2008 (First Publication: 1 February 2008)
  • Reduced-intensity conditioning (RIC) regimens have been increasingly used for allogeneic hematopoietic stem cell transplantation (HSCT) in follicular lymphoma (FL). We compared traditionalContinue Reading
  • Herman Waldmann, Geoff Hale, Gabriel Cividalli, Zeev Weshler, Shimon Slavin
  • Medicine
  • The Lancet
  • 1984 (First Publication: 1 September 1984)
  • A new monoclonal rat anti-human lymphocyte antibody (CAMPATH-1) which lyses cells with autologous human complement was used for depletion of T lymphocytes from human bone-marrow allografts in vitroContinue Reading
  • David Naor, Shlomo Nedvetzki, +13 authors Itshak Golan
  • Biology, Medicine
  • Annals of the New York Academy of Sciences
  • 2007 (First Publication: 1 September 2007)
  • CD44 is a multistructural and multifunctional glycoprotein, the diversity of which is generated by alternative splicing. In this communication we review some aspects related to CD44 structure andContinue Reading
  • Hillard M. Lazarus, Mei-Jie Zhang, +22 authors Parameswaran N. Hari
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2010
  • We compared outcomes of 916 diffuse large B cell lymphoma (DLBCL) patients aged >or=18 years undergoing first autologous (n = 837) or myeloablative (MA) allogeneic hematopoietic cell transplant (HCT)Continue Reading